A live audio webcast of the Evercore fireside chat and the H.C. Wainwright presentation will be available on the “Events” page of the Investors section of the COMPASS website.
Compound Psilocybin
Visit article
Category Press Release
Country United Kingdom
Companies Featured
COMPASS PathwaysCOMPASS Pathways is a publicly listed company (NASDAQ) that is developing psilocybin for treatment-resistant depression (TRD) for which it has completed a successful Phase IIb trial. COMPASS is one of the largest psychedelic companies and has received substantial investment from atai.